Cantor Fitzgerald, L. P. Merck & Co., Inc. Transaction History

Cantor Fitzgerald, L. P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $476,174 - $554,849	4,205 Added 74.81%	9,826 $1.3 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $54.1 Million - $58.8 Million	-539,698 Reduced 98.97%	5,621 $612,000
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $1.58 Million - $1.72 Million	-14,549 Reduced 2.6%	545,319 $62.9 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $86,057 - $96,022	-836 Reduced 0.15%	559,868 $59.6 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $5.18 Million - $6.65 Million	-59,295 Reduced 9.56%	560,704 $62.2 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $5.64 Million - $6.34 Million	66,758 Added 12.07%	619,999 $53.4 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $46.2 Million - $52.4 Million	553,241 New	553,241 $67.9 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.